Disruption of Placental Immune Privilege by Complications of Pregnancy: Consequences for Maternal and Child Health
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Wendy Kisaí Mixtega-Ruiz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Ciencias Biológicas, Centro Tlaxcala de Biología de la Conducta, Tlaxcala C.P. 90070, Mexico. Hauptthemen laut MEDLINE: Placenta, Pregnancy Complications, Immune Privilege. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Perinatología Isidro Espinosa de los Reyes, Instituto Nacional de Perinatología.
Abstract (Originalsprache)
Maternal chronic conditions, including obesity, diabetes, hypertensive disorders, and autoimmune diseases, promote a systemic proinflammatory environment characterized by oxidative stress and chronic inflammation. These alterations lead to reduced expressions of human leukocyte antigen-G (HLA-G) and programmed death-ligand 1 (PD-L1), decreased regulatory T (Treg)cell activity, and increased T helper (Th)1/Th17 responses, disrupting placental immune privilege and resulting in increased production of proinflammatory cytokines, oxidative stress, trophoblastic dysfunction, and placental senescence. This change in immune privilege contributes to fetal growth restriction, preterm birth, congenital anomalies, and long-term cardiometabolic programming in offspring. Understanding the mechanisms underlying placental immune dysregulation may facilitate the development of targeted therapeutic strategies aimed at restoring immune tolerance and reducing inflammatory and hypoxic signaling pathways to improve maternal and neonatal outcomes. This review summarizes the current state of the field of placental immunological privilege and how maternal chronic conditions like obesity, diabetes, hypertensive disorders, and autoimmune diseases can disrupt it and its possible consequences on the progeny.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctorado en Ciencias Biológicas, Centro Tlaxcala de Biología de la Conducta, Tlaxcala C.P. 90070, Mexico.
- Departamento de Inmunobioquímica, Instituto Nacional de Perinatología, Isidro Espinosa de los Reyes, Mexico City C.P. 11000, Mexico.
- Departamento de Investigación y Bioterio, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City C.P. 14080, Mexico.
- Coordinación de Genética y Genómica Humana Instituto Nacional de Perinatología, Mexico City C.P. 11000, Mexico.
- Dirección de Investigación, Instituto Nacional de Perinatología, Isidro Espinosa de los Reyes, Mexico City C.P. 11000, Mexico.
ORCID-Profile: Rosalba Sevilla-Montoya, Andrea Olmos-Ortiz, Verónica Zaga-Clavellina
Förderung
- National Institute of Perinatología Isidro Espinosa de los Reyes
- Instituto Nacional de Perinatología
Zitieren
APA
Mixtega-Ruiz, W. K., Contreras Escamilla, M., Sevilla-Montoya, R., Olmos-Ortiz, A., Zaga-Clavellina, V., & Castro-Rodríguez, D. C. (2026). Disruption of Placental Immune Privilege by Complications of Pregnancy: Consequences for Maternal and Child Health. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209247
Vancouver
Mixtega-Ruiz WK, Contreras Escamilla M, Sevilla-Montoya R, Olmos-Ortiz A, Zaga-Clavellina V, Castro-Rodríguez DC. Disruption of Placental Immune Privilege by Complications of Pregnancy: Consequences for Maternal and Child Health. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209247
BibTeX
@article{MixtegaRuiz2026,
author = {Mixtega-Ruiz, Wendy Kisaí and Contreras Escamilla, Mariela and Sevilla-Montoya, Rosalba and Olmos-Ortiz, Andrea and Zaga-Clavellina, Verónica and Castro-Rodríguez, Diana Catalina},
title = {Disruption of Placental Immune Privilege by Complications of Pregnancy: Consequences for Maternal and Child Health},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209247}
}
EUVIMED